Physician profile
Desmond Thomas
NPI 1548448475
$6,796.75
in general payments reported to CMS, 2019-2025
25 companies · $2,330 in 2025
The $2,330 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $42.61 · 2021: $195 · 2022: $525 · 2023: $456 · 2024: $3,132 · 2025: $2,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,805 · Travel and Lodging: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,805.07 |
| Travel and Lodging | $1,112.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,757.49 | 2022-2025 | |
| Abbvie INC. | $364.48 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $196.05 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $187.22 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $173.85 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Caldera Medical, INC | $167.84 | 2024 | Desara |
| Coopersurgical, INC. | $164.64 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Axonics, INC. | $141.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.97 | 2021-2025 | |
| Aspira Women'S Health INC | $80.00 | 2023 | Ova1 |
| Lsi Solutions INC | $54.26 | 2025 | Fornisee |
| Pfizer INC. | $47.55 | 2019-2023 | |
| Biogen, INC. | $45.67 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $41.06 | 2022-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $34.15 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $32.21 | 2022 | |
| Duchesnay USA Incorporated | $31.87 | 2019 | |
| Organon LLC | $26.38 | 2023-2024 | |
| Amag Pharmaceuticals, INC. | $24.99 | 2019 | |
| Optumhealth Care Solutions, LLC | $19.55 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $18.79 | 2021 | |
| Millicent US INC | $18.73 | 2025 | Femlyv |
| Shield Therapeutics INC | $16.60 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $14.71 | 2019 | |
| Merck Sharp & Dohme LLC | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desmond Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.